Laboratory diagnosis of cryptococcal meningitis in an HIV-infected patient
https://doi.org/10.18705/2782-3806-2024-4-4-361-369
EDN: ZEDPSF
Abstract
Experiences in Cryptococcus neoformans meningitis laboratory diagnosis in HIV infected patient are presented.
About the Authors
I. V. GorbovaRussian Federation
Inna V. Gorbova, Head of the Laboratory
Laboratory for Clinical Expert and Express Diagnostics
Saint Petersburg
Yu. I. Zhilenkova
Russian Federation
Yulia I. Zhilenkova, Associate Professor
Department of Laboratory Medicine with Сlinic
Saint Petersburg
P. B. Filippova
Russian Federation
Polina B. Filippova, Resident
Department of Laboratory Medicine with Сlinic
197341; Akkuratova str., 2; Saint Petersburg
M. V. Shulgina
Russian Federation
Marina V. Shulgina, Professor
Department of Laboratory Medicine with Сlinic
Saint Petersburg
References
1. Rajasingham R, Govender NP, Jordan A, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022 Dec;22(12):1748–1755. DOI: 10.1016/S1473-3099(22)00499-6.
2. Brizendine KD, Baddley JW, Pappas PG. Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status. PLoS One 2013;8(3):e60431–e60431. DOI: 10.1371/journal.pone.0060431.
3. World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. https://www.who.int/publications/i/item/9789240060241 (October 25, 2022).
4. Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis 2014;14:813–819.
5. Pyrgos V, Seitz AE, Steiner CA, et al. Epidemiology of cryptococcal meningitis in the US: 1997–2009. PLoS One 2013;8(2):e56269–e56269.
6. Chashurina IP, Zotova NV. Clinical and morphological characteristics of cryptococcosis in HIV infection. Journal of Infectology. 2012. Vol. 4, 65–70. In Russian
7. Rahmanova AG, Yakovlev AA, Volkova GV, et al. Organization of therapeutic and diagnostic activities for patients with severe forms of HIV infection accompanied by secondary and opportunistic diseases // Infectious Diseases 2007. Almanac. 2007. P. 192–198. In Russian
8. SanPiN 3.3686–21 “Sanitary and Epidemiological Requirements for the Prevention of Infectious Diseases” VI. Prevention of HIV Infection. In Russian
9. Clinical Guidelines of the Ministry of Health of the Russian Federation. HIV Infection in Adults, 2020. Clinical Guidelines Index. In Russian https://cr.minzdrav.gov.ru/recomend/79_1
10. Chen Y, et al. Cryptococcus neoformans Infection in the Central Nervous System: The Battle between Host and Pathogen. J Fungi (Basel). 2022 12;8(10):1069.
11. Meya DB, Williamson PR. Cryptococcal Disease in Diverse Hosts .N Engl J Med. 2024;390(17):1597–1610.
12. Musatov VB, Yakovlev AA, Andreeva SG, Stavickaya TV. Clinical and laboratory characteristic of cases of primary HIV infection with the central nervous system impairment. Journal Infectology. 2012;4(2):40–45. In Russian
13. Leonova ON, Stepanova EV, Shelomov AS. Cryptococcal infection in HIV-infected patients. Bulletin of Hematology. Vol. XVI, No. 3, 2020. In Russian
Review
For citations:
Gorbova I.V., Zhilenkova Yu.I., Filippova P.B., Shulgina M.V. Laboratory diagnosis of cryptococcal meningitis in an HIV-infected patient. Russian Journal for Personalized Medicine. 2024;4(4):361-369. (In Russ.) https://doi.org/10.18705/2782-3806-2024-4-4-361-369. EDN: ZEDPSF